MPM BioImpact’s Ventyx Biosciences VTYX Stock Holding History

MPM BioImpact’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,639,061	Closed	-$14.8M	–	48
2025 Q4	$14.8M	Buy	+1,639,061	New	+$12.2M	1.69%	28
2023 Q3	–	Sell	-31,747	Closed	-$1.04M	–	34
2023 Q2	$1.04M	Buy	+31,747	New	+$1.09M	0.21%	33

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MPM BioImpact's VTYX Position: Q1 2026 in Review

MPM BioImpact sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 1,639,061 shares — an estimated $14.8M sold.

MPM BioImpact first reported a position in VTYX in Q2 2023 and held it in 2 quarters. The position peaked at $14.8M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

MPM BioImpact reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
MPM BioImpact sold 1,639,061 Ventyx Biosciences shares in Q1 2026, an estimated $14.8M.
MPM BioImpact first reported a position in Ventyx Biosciences in Q2 2023 and held it in 2 quarters.
MPM BioImpact's Ventyx Biosciences position peaked at $14.8M in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on MPM BioImpact's 13F filing for Q1 2026, filed 15 May 2026.